MDT

100.74

+2.67%↑

139.57

+3.45%↑

VEEV

220.73

+2.22%↑

HQY

85.25

+0.74%↑

NEOG

9.86

+6.71%↑

MDT

100.74

+2.67%↑

139.57

+3.45%↑

VEEV

220.73

+2.22%↑

HQY

85.25

+0.74%↑

NEOG

9.86

+6.71%↑

MDT

100.74

+2.67%↑

139.57

+3.45%↑

VEEV

220.73

+2.22%↑

HQY

85.25

+0.74%↑

NEOG

9.86

+6.71%↑

MDT

100.74

+2.67%↑

139.57

+3.45%↑

VEEV

220.73

+2.22%↑

HQY

85.25

+0.74%↑

NEOG

9.86

+6.71%↑

MDT

100.74

+2.67%↑

139.57

+3.45%↑

VEEV

220.73

+2.22%↑

HQY

85.25

+0.74%↑

NEOG

9.86

+6.71%↑

Home・Aktien・Prometheus Biosciences Inc

Prometheus Biosciences Inc

Open

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

Max

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	+0.04% upside

Prometheus Biosciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

20. Jan. 2026, 23:43 UTC

Market Talk

Gold Consolidates; May Face Technical Correction -- Market Talk

20. Jan. 2026, 23:42 UTC

Market Talk

Nikkei May Fall Amid Concerns Over U.S.-Europe Trade Relations -- Market Talk

20. Jan. 2026, 23:41 UTC

Ergebnisse

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- 2nd Update

20. Jan. 2026, 23:29 UTC

Market Talk

RBA Rate Hike in February Would Be a Painful One -- Market Talk

20. Jan. 2026, 23:26 UTC

Market Talk

Global Equities Roundup: Market Talk

20. Jan. 2026, 23:26 UTC

Market Talk

James Hardie Appeals More as Reece's U.S. Strategy Comes Under Scrutiny -- Market Talk

20. Jan. 2026, 22:45 UTC

Akquisitionen, Fusionen, Übernahmen

ACCC: Ampol-EG Deal Is First Assessment Subject to Phase 2 Review Under New Merger Control Regime

20. Jan. 2026, 22:45 UTC

Akquisitionen, Fusionen, Übernahmen

ACCC Seeks Submissions in Response to Phase 2 Notice by February 4

20. Jan. 2026, 22:44 UTC

Akquisitionen, Fusionen, Übernahmen

ACCC: Ampol's Offer to Sell 19 Retail Fuel Sites Doesn't Adequately Address Issues

20. Jan. 2026, 22:44 UTC

Akquisitionen, Fusionen, Übernahmen

ACCC Identifies 115 EG Sites Where Deal Could Substantially Lessen Competition

20. Jan. 2026, 22:43 UTC

Akquisitionen, Fusionen, Übernahmen

ACCC Says Deal Could Substantially Lessen Competition in Retail Supply of Petrol, Diesel in Several Markets in Australia

20. Jan. 2026, 22:43 UTC

Akquisitionen, Fusionen, Übernahmen

Ampol's Acquisition of EG Australia to Undergo In-Depth Review by Competition Regulator

20. Jan. 2026, 22:27 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Plans to Roll Out New Mobile User Interface Later This Year, Co-CEO Says

20. Jan. 2026, 22:25 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Co-CEO Sees Uptick in Engagement for TV-Based Games

20. Jan. 2026, 22:21 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Would Keep 45-Day Theater Release Window for Warner Bros. Films, Co-CEO Says

20. Jan. 2026, 22:20 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Excited to Strengthen Warner Bros.'s Theatrical-Distribution Business, Co-CEO Says

20. Jan. 2026, 22:19 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Pleased With Early Results for Podcasts, Co-CEO Says

20. Jan. 2026, 22:18 UTC

Ergebnisse

Netflix Stock Is Falling. This Is Overshadowing the Streamer's Earnings Beat. -- Barrons.com

20. Jan. 2026, 22:17 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix's Live Events Are Boosting Retention, Co-CEO Says

20. Jan. 2026, 22:16 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Remains 'Very Excited' About Live-Events Offering, Co-CEO Says

20. Jan. 2026, 22:15 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix's Proposed Deal for Warner Bros. Would Protect, Create Jobs, Co-CEO Says

20. Jan. 2026, 22:15 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Competes for Attention Across Streaming, Broadcast, Cable, Gaming, Social Media, Video Platforms, Co-CEO Says

20. Jan. 2026, 22:13 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Co-CEO: TV Landscape Has Never Been More Competitive

20. Jan. 2026, 22:11 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Confident Warner Bros. Deal Would Pass Regulatory Review, Co-CEO Says

20. Jan. 2026, 22:10 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Would Leverage Global Footprint, Streaming Expertise to Improve Warner Bros.'s HBO Max Service, Co-CEO Says

20. Jan. 2026, 22:08 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Won't Raise Prices During Regulatory-Review Process for Pending Warner Bros. Deal, Co-CEO Says

20. Jan. 2026, 22:07 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Sees Warner Bros. as Another Mechanism to Improve Offerings, Co-CEO Says

20. Jan. 2026, 22:06 UTC

Ergebnisse

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- Update

20. Jan. 2026, 22:00 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

ESG Roundup: Market Talk

20. Jan. 2026, 21:50 UTC

Market Talk

Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Prometheus Biosciences Inc Prognose

Kursziel

By TipRanks

0.04% Vorteil

12-Monats-Prognose

Durchschnitt 200 USD 0.04%

Hoch 200 USD

Tief 200 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Prometheus Biosciences Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

7 ratings

Buy

Halten

Sell

Basierend auf 7 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Prometheus Biosciences Inc – Dist abgegeben haben.

Finanzen

Andere Aktien aus dem Sektor

MDT

Medtronic PLC

100.74

↑ +2.67%

Agilent Technologies Inc

139.57

↑ +3.45%

VEEV

Veeva Systems Inc

220.73

↑ +2.22%

HQY

HealthEquity Inc

85.25

↑ +0.74%

NEOG

Neogen Corp

9.86

↑ +6.71%

Prometheus Biosciences Inc

Übersicht

Veränderung der Aktienkurses

Empfehlungen

Prometheus Biosciences Inc Chart

Ähnliche Nachrichten

Peer-Vergleich

Prometheus Biosciences Inc Prognose

Kursziel

Rating-Konsens

Finanzen

Andere Aktien aus dem Sektor